Jaai Dev Hospital Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 11-01-2025
- Paid Up Capital ₹ 0.20 M
as on 11-01-2025
- Company Age 13 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 Cr
as on 11-01-2025
- Revenue 134.99%
(FY 2022)
- Profit 278.84%
(FY 2022)
- Ebitda 470.44%
(FY 2022)
- Net Worth 24.66%
(FY 2022)
- Total Assets 6.56%
(FY 2022)
About Jaai Dev Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹5.00 Cr.
Ramasamy Palanivel, Durairaj Gokulraj, Palanivel Ramasamy, and Four other members serve as directors at the Company.
- CIN/LLPIN
U85110TZ2011PTC017086
- Company No.
017086
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 May 2011
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Salem, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Jaai Dev Hospital?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramasamy Palanivel  | Director | 17-Aug-2019 | Current |
| Durairaj Gokulraj | Director | 03-Mar-2014 | Current |
| Palanivel Ramasamy | Director | 03-Mar-2014 | Current |
| Kaleeswaran Balasubramaniam | Director | 17-Aug-2019 | Current |
| Priyadharshini Arumugam | Director | 17-Aug-2019 | Current |
| Palanisamy Arumugam | Director | 22-May-2011 | Current |
Financial Performance of Jaai Dev Hospital.
Jaai Dev Hospital Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 134.99% increase. The company also saw a substantial improvement in profitability, with a 278.84% increase in profit. The company's net worth Soared by an impressive increase of 24.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jaai Dev Hospital?
In 2021, Jaai Dev Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Corporation Bank Creation Date: 30 Dec 2015 | ₹5.00 Cr | Open |
How Many Employees Work at Jaai Dev Hospital?
Jaai Dev Hospital has a workforce of 43 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jaai Dev Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jaai Dev Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
